Phase 2 Results of Pitolisant in Prader-Willi Syndrome : vim

Harmony Biosciences will present new efficacy data from a phase 2 study evaluating pitolisant in patients with Prader-Willi syndrome.

Related Keywords

Kumar Budur , Drug Administration , Harmony Biosciences Holdings Inc , Meaningful Improvements , Pooled Analysis , Randomized Clinical Trials , Presentation Date , Board Number , Safety Results , Placebo Controlled Proof , Signal Detection Study , Prader Willi Syndrome ,